Amid all the bad news at Pershing Square Capital Management – its long bet on Valeant Pharmaceuticals is down again today and its rare short on Herbalife is breaking into new yearly highs – there are signs of improvement. Considering the HSBC Hedge Weekly performance ranking for instance.
Also see the top hedge fund letters
Pershing Square is almost out off the 20 worst performers list
William Ackman’s $3.9 billion activist fund, Pershing Square, has been on the list of 20 worst performers for nearly as long as its current drawdown. In 2015 the fund was the 11th worst performer, down 16.66%. This followed the...


